$48.61
-0.64-1.3%
At close: Sep 18, 5:00 PM EST
$49.75
1.142.35%
After Hours: Sep 14, 5:43 PM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Virtus Biotech Clinical Trials ETF (BBC) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
46.23M
Fund Score
Loading...
Key Statistics
Open
$49.12
High
$49.12
52 Wk High
$56.18
AUM
46.23M
Dividend
$0.66
Ex-Div Date
Dec 22, 2025
Volume
9.3K
Market Cap
-
Mgmt Fee
0.65%
P/E Ratio
-
Prev. Close
$49.25
Low
$48.33
52 Wk Low
$24.12
Shares Out
400.00K
Yield
1.35%
Div. Freq
-
Avg. Volume Daily
16.73K
Beta
0.89
Avg. Expense Ratio
0.65%
P/B Ratio
-
Recent Virtus Biotech Clinical Trials ETF News
FAQ
Q
How do I buy Virtus Biotech Clinical Trials ETF (BBC) stock?
A
You can purchase shares of Virtus Biotech Clinical Trials ETF (ARCA:BBC) through any online brokerage.
Q
Who are Virtus Biotech Clinical Trials ETF (BBC) competitors?
A
There are no as such competitors for Virtus Biotech Clinical Trials ETF.
Q
What is the forecast, or price target, for Virtus Biotech Clinical Trials ETF (BBC) stock?
A
There is no analysis for Virtus Biotech Clinical Trials ETF to provide a consensus price target.
Q
What is the current price for Virtus Biotech Clinical Trials ETF (BBC)?
A
The stock price for Virtus Biotech Clinical Trials ETF (ARCA: BBC) is $49.75 last updated September 14, 2026 at 5:43 PM EDT.
Q
Does Virtus Biotech Clinical Trials ETF (BBC) pay a dividend?
A
There are no upcoming dividends for Virtus Biotech Clinical Trials ETF.
Q
When is Virtus Biotech Clinical Trials ETF (ARCA:BBC) reporting earnings?
A
Virtus Biotech Clinical Trials ETF does not have any upcoming earnings scheduled.
Q
Is Virtus Biotech Clinical Trials ETF (BBC) going to split?
A
There is no upcoming split for Virtus Biotech Clinical Trials ETF.
Key Statistics
Open
$49.12
High
$49.12
52 Wk High
$56.18
AUM
46.23M
Dividend
$0.66
Ex-Div Date
Dec 22, 2025
Volume
9.3K
Market Cap
-
Mgmt Fee
0.65%
P/E Ratio
-
Prev. Close
$49.25
Low
$48.33
52 Wk Low
$24.12
Shares Out
400.00K
Yield
1.35%
Div. Freq
-
Avg. Volume Daily
16.73K
Beta
0.89
Avg. Expense Ratio
0.65%
P/B Ratio
-
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Small Cap Growth |
| Fund Inception | Dec 16, 2014 |
| Managers | Matthew B. Brown Seth Kadushin |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved